Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News

  News Archive

WGBS Announces Research Collaboration with Leading Canadian Laboratory
Saturday, March 07, 2015
Goal of enabling affordable, large-scale BRCA1 and BRCA2 screening for general population.

‘Liquid Biopsies’ Could Help Spot Genetic Faults in Lung Cancer
Saturday, March 07, 2015
Study analyze blood samples from 97 patients who took part in the EURTAC clinical trial.

ModiQuest Research and Cellectis to Collaborate
Saturday, March 07, 2015
Collaboration on antibody generation for potential CAR development.

Arrowhead Acquires Novartis' RNAi R&D Portfolio
Friday, March 06, 2015
The acquisition includes multiple patent families covering RNAi-trigger design rules and modifications.

In vivo CRISPR-Cas9 Screen Sheds Light On Cancer Metastasis And Tumor Evolution
Friday, March 06, 2015
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens.

TSRI Scientists Find Clues to Cancer Drug Failure
Thursday, March 05, 2015
A pair of studies show how the primary protein responsible for multidrug chemotherapy resistance changes shape.

MR Spectroscopy Shows Precancerous Breast Changes in Women with BRCA Gene
Thursday, March 05, 2015
A technique that monitors biochemical changes in tissue could improve the management of women at risk of breast cancer.

New Nanodevice Defeats Drug Resistance
Wednesday, March 04, 2015
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.

Regulatory Submission for Phase 2b Trial for Novel AML Consolidation Treatment
Tuesday, March 03, 2015
BL-8040 Phase 2b study, as consolidation treatment for AML patients responding to standard induction treatment, is expected to commence shortly after receipt of regulatory approval, anticipated in next few months.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 3325
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters